Prevalence of bleeding secondary to anticoagulation and mortality in patients with atrial fibrillation admitted with SARS-CoV-2 infection

Mostrar otras versiones (1)

INTRODUCTION AND PURPOSE: Atrial fibrillation (AF) is common in patients admitted with severe COVID-19. However, there is limited data about the management of chronic anticoagulation therapy in these patients. We assessed the anticoagulation and incidence of major cardiovascular events in hospitaliz...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubini-Costa, Ricardo, Bermúdez-Jiménez, Francisco, Rivera-López, Ricardo, Sola-García, Elena, Nagib-Raya, Hadi, Moreno-Escobar, Eduardo, López-Zúñiga, Miguel Ángel, Briones-Través, Adela, Sanz-Herrera, Francisco, Sequí-Sabater, Jose Miguel, Romero-Cabrera, Juan Luis, Maíllo-Seco, Javier, Fernández-Vázquez, Felipe, Rivadeneira-Ruiz, María, López-Valero, Lucas, Gómez-Navarro, Carlos, Aparicio-Gómez, Jose Antonio, López, Miguel Álvarez, Tercedor, Luis, Molina-Jiménez, María, Macías-Ruiz, Rosa, Jiménez-Jáimez, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279935/
https://www.ncbi.nlm.nih.gov/pubmed/34364707
http://dx.doi.org/10.1016/j.medcli.2021.06.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279935/
https://www.ncbi.nlm.nih.gov/pubmed/34364707
http://dx.doi.org/10.1016/j.medcli.2021.06.015

Ejemplares similares